AR050984A1 - Derivados de benceno halogenados sustituidos con trimeros macrociclicos - Google Patents

Derivados de benceno halogenados sustituidos con trimeros macrociclicos

Info

Publication number
AR050984A1
AR050984A1 ARP050101791A ARP050101791A AR050984A1 AR 050984 A1 AR050984 A1 AR 050984A1 AR P050101791 A ARP050101791 A AR P050101791A AR P050101791 A ARP050101791 A AR P050101791A AR 050984 A1 AR050984 A1 AR 050984A1
Authority
AR
Argentina
Prior art keywords
atom
benchen
macrociclic
trimers
halogenated
Prior art date
Application number
ARP050101791A
Other languages
English (en)
Spanish (es)
Inventor
R Harto Juan
L Martin Jose
Platzek Johannes
Schirmer Heiko
Weinmann Hanns-Joachim
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of AR050984A1 publication Critical patent/AR050984A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0438—Organic X-ray contrast-enhancing agent comprising an iodinated group or an iodine atom, e.g. iopamidol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
ARP050101791A 2004-05-05 2005-05-04 Derivados de benceno halogenados sustituidos con trimeros macrociclicos AR050984A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004023093A DE102004023093B3 (de) 2004-05-05 2004-05-05 Trimere makrocyclisch substituierte Halogen-Benzolderivate

Publications (1)

Publication Number Publication Date
AR050984A1 true AR050984A1 (es) 2006-12-13

Family

ID=34967980

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050101791A AR050984A1 (es) 2004-05-05 2005-05-04 Derivados de benceno halogenados sustituidos con trimeros macrociclicos

Country Status (18)

Country Link
US (1) US7385054B2 (de)
EP (1) EP1742926B1 (de)
JP (1) JP2007536295A (de)
AR (1) AR050984A1 (de)
AT (1) ATE369347T1 (de)
DE (2) DE102004023093B3 (de)
DK (1) DK1742926T3 (de)
ES (1) ES2289711T3 (de)
GT (1) GT200500106A (de)
PA (1) PA8632101A1 (de)
PE (1) PE20060350A1 (de)
PL (1) PL1742926T3 (de)
PT (1) PT1742926E (de)
SI (1) SI1742926T1 (de)
SV (1) SV2006002104A (de)
TW (1) TW200539894A (de)
UY (1) UY28884A1 (de)
WO (1) WO2005108379A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007058220A1 (de) 2007-12-03 2009-06-04 Bayer Schering Pharma Aktiengesellschaft Dimere macrocyclisch substituierte Benzolderivate
KR101209633B1 (ko) * 2009-09-09 2012-12-06 주식회사 휴메딕스 페길레이션된 삼요오드화 아릴 화합물 및 그를 포함하는 ｘ-선 조영제
EP3101012A1 (de) 2015-06-04 2016-12-07 Bayer Pharma Aktiengesellschaft Neue gadoliniumchelat-verbindung zur verwendung in der magnetresonanzbildgebung
CN110035996B (zh) 2016-11-28 2022-08-09 拜耳医药股份公司 用于磁共振成像的新型高弛豫性钆螯合物
KR20210095168A (ko) 2018-11-23 2021-07-30 바이엘 악티엔게젤샤프트 조영 매체의 제형 및 그의 제조 방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5324503A (en) * 1992-02-06 1994-06-28 Mallinckrodt Medical, Inc. Iodo-phenylated chelates for x-ray contrast
AU6996594A (en) * 1993-06-02 1994-12-20 Bracco S.P.A. Iodinated paramagnetic chelates, and their use as contrast agents
US7208140B2 (en) 2003-02-19 2007-04-24 Schering Aktiengesellschaft Trimeric macrocyclic substituted benzene derivatives
DE10307759B3 (de) * 2003-02-19 2004-11-18 Schering Ag Trimere makrocyclisch substituierte Benzolderivate, deren Herstellung und Verwendung als Kontrastmittel sowie diese enthaltende pharmazeutische Mittel

Also Published As

Publication number Publication date
DE102004023093B3 (de) 2006-03-02
GT200500106A (es) 2005-12-15
TW200539894A (en) 2005-12-16
WO2005108379A1 (de) 2005-11-17
PL1742926T3 (pl) 2007-12-31
DK1742926T3 (da) 2007-10-15
PT1742926E (pt) 2007-09-24
JP2007536295A (ja) 2007-12-13
DE502005001194D1 (de) 2007-09-20
EP1742926B1 (de) 2007-08-08
UY28884A1 (es) 2005-11-30
PA8632101A1 (es) 2006-07-03
US20060154989A1 (en) 2006-07-13
SI1742926T1 (sl) 2007-12-31
US7385054B2 (en) 2008-06-10
SV2006002104A (es) 2006-02-15
PE20060350A1 (es) 2006-05-25
EP1742926A1 (de) 2007-01-17
ATE369347T1 (de) 2007-08-15
ES2289711T3 (es) 2008-02-01

Similar Documents

Publication Publication Date Title
AR121044A1 (es) Inhibidores de egfr
AR050984A1 (es) Derivados de benceno halogenados sustituidos con trimeros macrociclicos
ATE387429T1 (de) Arly- und heteroaryl-substituierte tetrahydroisoquinoline und ihre verwendung als hemmer der wiederaufnahme von norepinephrin, dopamin und serotonin
AR107193A2 (es) Compuesto de benzoazepina hidrosoluble y composición farmacéutica
CO6341610A2 (es) Compuesto heterociclilo aromatico que contiene nitrogeno.
AR034897A1 (es) Derivados n-monoacilados de o-fenilendiaminas, sus analogos heterociclicos de seis miembros y su uso como agentes farmaceuticos
EA200500017A1 (ru) Новые соединения
ATE520676T1 (de) 5-hydroxy-benzothiazol-derivate mit der aktivität von beta-2-adrenorezeptoragonisten
RS52881B (en) BENZAMIDINE COMPOUNDS USED AS HISTONAL DEACETYLASE INHIBITORS
ES2721172T3 (es) Una nueva clase de moléculas terapéuticas a base de proteínas
CO5700801A2 (es) Tratamiento del transtorno por deficit de atencion con hiper actividad
ES2192520T3 (es) Composicion farmaceutica.
CO5631438A2 (es) Profarmacos de aminoacidos excitadores
DK2203430T3 (da) N-phenyl-dioxo-hydropyrimidiner anvendelige som inhibitorer for hepatitis C virus (HCV)
CY1109441T1 (el) Ενδιαμεσα προϊοντα για την παραγωγη διοξανιου-2-αλκυλκαρβαμικου
AR044706A2 (es) Procedimientos para preparar 4-aminoquinolinas, inhibidores de cetp
AR057408A1 (es) Agonistas del receptor de niacina composiciones que contienen tales compuestos y procedimientos para tratamiento
UY30009A1 (es) Compuestos benzoilpirazol y herbicidas que los contienen
AR043205A1 (es) Derivados de benceno sustituidos con trimeros macrociclicos
CO5060426A1 (es) 1-aril-3-imidiopirazoles plaguicidas
CR7249A (es) Derivados de diamina, proceso para producir los derivados de diamina, y funguicidas que contienen los derivados de diamina como ingrediente activo
BR112013024957A2 (pt) derviado de furanona ou um sal farmaceuticamente aceitável do mesmo
ES2177275T3 (es) Derivados de oxadiazolina y su uso como insecticidas.
CO6220909A2 (es) Moduladores de cannabinoides hexahidro-cicloheptapirazol
AR047742A1 (es) Compuestos con actividad antitumoral

Legal Events

Date Code Title Description
FA Abandonment or withdrawal